Open AccessTNF-Alpha Blockers in Inflammatory Bowel Diseases: Practical Recommendations and a User’s Guide: An Update
Author(s) -
Marianne Vulliemoz,
Stephan Brand,
Pascal Juillerat,
Christian Mottet,
Shomron BenHorin,
Pierre Michetti
Publication year - 2020
Publication title -
digestion
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.882
H-Index - 75
eISSN - 1421-9867
pISSN - 0012-2823
DOI - 10.1159/000506898
Subject(s) - medicine , biosimilar , tumor necrosis factor alpha , inflammatory bowel disease , inflammatory bowel diseases , pharmacology , immunology , disease
Anti-tumour necrosis factor-alpha (anti-TNF) antagonists have been the mainstay in the treatment of inflammatory bowel diseases (IBDs) for over 20 years.